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Abstract 
This study aimed to test for overlap in genetic influences between psychotic-like experience 
traits shown by adolescents in the community, and clinically-recognized psychiatric disorders 
in adulthood, specifically schizophrenia, bipolar disorder, and major depression. The full 
spectra of psychotic-like experience domains, both in terms of their severity and type 
(positive, cognitive, and negative), were assessed using self- and parent-ratings in three 
European community samples aged 15-19 years (Final N incl. siblings = 6,297-10,098). A 
mega-genome-wide association study (mega-GWAS) for each psychotic-like experience 
domain was performed. SNP-heritability of each psychotic-like experience domain was 
estimated using genomic-relatedness-based restricted maximum-likelihood (GREML) and 
linkage disequilibrium- (LD-) score regression. Genetic overlap between specific psychotic-
like experience domains and schizophrenia, bipolar disorder, and major depression was 
assessed using polygenic risk scoring (PRS) and LD-score regression. GREML returned 
SNP-heritability estimates of 3-9% for psychotic-like experience trait domains, with higher 
estimates for less skewed traits (Anhedonia, Cognitive Disorganization) than for more 
skewed traits (Paranoia and Hallucinations, Parent-rated Negative Symptoms). Mega-GWAS 
analysis identified one genome-wide significant association for Anhedonia within IDO2 but 
which did not replicate in an independent sample. PRS analysis revealed that the 
schizophrenia PRS significantly predicted all adolescent psychotic-like experience trait 
domains (Paranoia and Hallucinations only in non-zero scorers). The major depression PRS 
significantly predicted Anhedonia and Parent-rated Negative Symptoms in adolescence. 
Psychotic-like experiences during adolescence in the community show additive genetic 
effects and partly share genetic influences with clinically-recognized psychiatric disorders, 
specifically schizophrenia and major depression.  
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Text 
Introduction 
Psychotic-like experiences, also referred to as psychotic-like experiences, are traits in 
the community that at the extreme resemble symptoms of psychotic disorders, such as 
schizophrenia. Based on principal component analyses, psychotic-like experiences can be 
separated into replicable and specific domains, such as positive, cognitive and negative 
domains [Ronald et al., 2014; Wigman et al., 2012]. Psychotic-like experiences are common 
in the general population, particularly during adolescence [Freeman, 2006; Ronald et al., 
2014]. Evidence suggests that psychotic-like experiences are dimensional: they show varying 
degrees of severity and taxometric analyses support their continuous nature in adolescence 
[Ahmed et al., 2012; Daneluzzo et al., 2009; Taylor et al., 2016]. Adolescence is just prior to 
a peak time of onset for several psychiatric disorders, particularly schizophrenia, bipolar 
disorder, and major depression [Laursen et al., 2007]. Psychotic-like experiences predict 
many types of psychiatric disorders and suicidal ideation with significant odds ratios of 1.3-
5.6 [Cederlöf et al., 2016; Fisher et al., 2013; Kelleher et al., 2012, 2014; McGrath et al., 
2016; Werbeloff et al., 2012; Zammit et al., 2013]. 
Twin studies report modest heritability of psychotic-like experience domains with 
typically between a third and a half of the variance explained by genetic influences [Ericson 
et al., 2011; Hay et al., 2001; Hur et al., 2012; Linney et al., 2003; Polanczyk et al., 2010; 
Wigman et al., 2011; Zavos et al., 2014]. One study to date has reported SNP-heritability 
estimates ranging from 0-32%. These results suggest that common genetic variation plays a 
role in at least some types of adolescent psychotic-like experiences [Sieradzka et al., 2015], 
but larger studies are needed to offer accurate estimates. 
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The one previous genome-wide association study (GWAS) of adolescent psychotic-
like experiences assigned 3,483 individuals to high- or low-scoring groups based on a 
measure of positive psychotic-like experiences that combined paranoia, hallucinations and 
delusions [Zammit et al., 2014]. No locus achieved genome-wide significance.  
The Psychiatric Genomics Consortium 2 schizophrenia GWAS has been previously 
used twice to test for an association between genetic risk of schizophrenia and adolescent 
psychotic-like experiences (these followed one study using Psychiatric Genomics Consortium 
1 schizophrenia GWAS results [Zammit et al., 2014]). The first of these studies used 
quantitative measures of individual psychotic-like experiences in adolescence in a sample of 
N=2,133-2,140 and reported no significant positive association between any of the psychotic-
like experience domains and schizophrenia genetic risk [Sieradzka et al., 2014]. This study 
also reported no significant positive association with bipolar disorder genetic risk. A second 
study with N=3,676-5,444 tested for an association between schizophrenia genetic risk and 
dichotomous outcomes on several scales: a combined positive psychotic-like experiences 
scale (which included paranoia, hallucinations, delusions, and thought interference), a 
negative symptoms scale, a depressive disorder scale, and an anxiety disorder scale [Jones et 
al., 2016]. This second study reported a significant positive association between 
schizophrenia genetic risk and both high negative symptoms and high anxiety disorder. There 
was no association with the positive psychotic-like experiences or depressive disorder scales. 
Schizotypal traits are closely related to psychotic-like experiences. Schizotypal traits 
focus on differences in personality that reflect liability to psychotic disorders rather than the 
presentation of subclinical psychotic-like experiences. Previous twin studies of schizotypal 
traits report modest heritability [Ericson et al., 2011; Lin et al., 2007], and studies are starting 
to explore the link between polygenic risk for schizophrenia and schizotypal traits 
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[Hatzimanolis et al., 2017]. In light of the differences in the constructs of schizotypy and 
psychotic-like experiences we focused our brief review on psychotic-like experiences. 
Our study aimed to test for overlap in genetic influences between specific psychotic-
like experience domains in adolescence and psychiatric disorders - specifically, schizophrenia, 
bipolar disorder, and major depression. Four psychotic-like experience subscales were used, 
derived from principal component analysis: Paranoia and Hallucinations, Cognitive 
Disorganization, Anhedonia, and Parent-rated Negative Symptoms. We also present the 
largest GWAS to date of adolescent psychotic-like experiences using a community sample of 
6,297-10,098 individuals (including siblings) from three European studies. As such our study 
also aimed to identify novel common genetic variants associated with specific psychotic-like 
experience domains and to estimate their SNP-heritability.  
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Materials and Methods 
Samples 
Three European general population samples of comparable ages were included: TEDS 
(Twins Early Development Study) [Haworth et al., 2013] a community sample born in 
England and Wales (mean age 16.32 years); ALSPAC (Avon Longitudinal Study of Parents 
and Children) [Boyd et al., 2012] a cohort from the United Kingdom (mean age 16.76 years); 
CATSS (Child and Adolescent Twin Study in Sweden [Anckarsäter et al., 2011]) a twin 
cohort in Sweden (mean age 18.31 years). Sample descriptions and ethical consent 
information are available in Supplementary Note 1. Standard exclusion criteria for GWASs 
of behavioral and cognitive traits were used (Supplementary Table 1)[Docherty et al., 2010].  
Measures 
We established comparable quantitative scales of psychotic-like experience domains 
across samples. The subscales in the Specific Psychotic Experiences Questionnaire, used in 
TEDS, were the starting point [Ronald et al., 2014]. The other two samples had used similar 
self-report items that were mapped onto domains of paranoia, hallucinations, cognitive 
disorganization and anhedonia, and parent-rated negative symptoms. The original measures 
available within each sample are listed in Supplementary Note 2. The content of each 
psychotic-like experience domain used within each sample is given in Supplementary Tables 
2-5. Cronbach’s alphas (measure of reliability) of each scale within each sample are listed in 
Table 1.  
Phenotypic harmonization 
Items were inspected to allow for harmonization of psychotic-like experience 
domains across samples via a two-stage process. First, two expert clinicians (AC and DF) 
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matched items across samples that were capturing the same underlying construct (to ensure 
construct and content validity) based on their clinical knowledge and experience with 
psychotic-like experience measures. Second, the matched items within each sample were 
analyzed via principal components analysis, a psychometric approach used to determine 
individual components underlying the items. This process was used to identify the presence 
of distinct psychotic-like experience domains. 
Individuals with >50% missingness for any psychotic-like experience domain were 
excluded from all analyses. The remaining missing phenotypic data was imputed using 
multiple imputation in R [Buuren and Groothuis-Oudshoorn, 2011]. Imputation of item level 
data was carried out separately for each sample and psychotic-like experience domain. 
Individual scores of the resulting psychotic-like experience subscales were calculated using 
sum scores. To ensure the equal contribution of each item to the sum score, item response 
values were rescaled to values between 0 and 1. The phenotypic correlations between specific 
psychotic-like experiences within each sample and in all samples combined are in 
Supplementary Table 6. Sum scores for each psychotic-like experience subscale were 
normalized using inverse rank-based normalization (data ties ranked randomly) and then 
standardized. The median correlation between a given scale before and after normalization 
was 0.92 (Supplementary Table 7), dependent on skew of the original scale. The normalized 
scores were then regressed against the following covariates: sex, age, age
2
, sex*age, sex*age
2
, 
study, and the top 8 principal components of ancestry. Principal components of ancestry were 
jointly calculated across all three samples using PLINK1.9 (https://www.cog-
genomics.org/plink2) [Chang et al., 2015] based only on observed genetic variation. 
Genotype imputation and quality control procedure 
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Genotypic data from each sample was imputed using the 1KG Phase 3 v5 to 
maximize genome-wide overlap between samples. After imputation, stringent variant and 
individual level quality control thresholds were applied in all samples before converting to 
hard-call genotypes (certainty threshold = 0.9) and merging the three datasets for combined 
analysis. For further information see Supplementary Note 3. Information on DNA collection 
and genotyping is given in Supplementary Note 4. 
Estimation of SNP-heritability 
SNP-heritability estimates were calculated within each sample and then meta-
analyzed to provide meta-SNP-heritability estimates. The meta-analysis of SNP-heritability 
estimates approach was taken to avoid a downward bias due to possible genetic heterogeneity 
between samples. Inverse variance weighted meta-analysis was used. Secondary analysis of 
mega-SNP-heritability, estimated across samples simultaneously, was also performed to 
estimate the proportion of phenotypic variance that could be explained by the mean genetic 
effects across sample.  
Two methods were used to estimate SNP-heritability: genomic-relatedness-matrix 
restricted maximum likelihood (GREML) in Genome-wide Complex Trait Analysis (GCTA), 
and linkage disequilibrium (LD)-score regression. Related individuals were included in both 
meta- and mega- GREML analyses [Zaitlen et al., 2013]. LD-score regression [Bulik-
Sullivan et al., 2015] was also performed within (meta-) and across (mega-) samples. The 
effective sample size was used in LD-score regression analyses, thus matching the sample in 
the GWAS. Effective sample size was calculated as follows: (2*sample size)/(1+correlation 
between siblings) [Minica et al., 2014]. There was no evidence of confounding from genome-
wide association results so the intercept was constrained to 1. 
Mega-genome-wide association study 
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The three samples were combined to enable genome-wide association mega-analysis. 
Genome-wide association analysis of all four psychotic-like experience domains using 
related (i.e. monozygotic and dizygotic twin pairs) and unrelated individuals was performed 
in PLINK (http://pngu.mgh.harvard.edu/purcell/plink/) [Purcell et al., 2007]. Additional 
covariance arises from related individuals; this was accounted for using the method of 
generalizable estimating equations (GEE) [Minica et al., 2014; Minică et al., 2015] in R 
specifying an exchangeable correlation matrix. 
Replication analysis of rs149957215 association with Anhedonia 
 After the discovery sample had been prepared and analysed for this project, an 
independent subsample of TEDS participants were genotyped. Of the newly genotyped 
individuals, 2,359 (incl. 635 MZ pairs) had reported on self-rated Anhedonia. This 
independent TEDS sample was used as a replication sample for the validation of the genome-
wide significant association between rs149957215 and Anhedonia identified by the mega-
GWAS in this study. rs149957215 genotypes were imputed (MACH r
2
 = 0.93) using the 
haplotype reference consortium data via the Sanger imputation server [McCarthy et al., 2016]. 
The genotypic data was converted to hard-call format (certainty threshold of 0.9) and 
analyzed in PLINK using the same GEE method to account for relatives. This replication 
analysis had a power of 0.86 to detect an association of the same magnitude (r
2
 = 0.47%) at 
nominal significance. 
Gene-based association analysis 
Two gene-based association analyses were performed. The first aggregates SNP 
associations within specific gene regions using the MAGMA program [de Leeuw et al., 2015]. 
The second analysis used PrediXcan [Gamazon et al., 2015] to predict frontal cortex gene 
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expression differences using genotypic data. Further details can be found in Supplementary 
Note 5. 
Genetic association between psychotic-like experience domains and psychiatric disorders 
Using the software PRSice [Euesden et al., 2015], polygenic risk scores (PRSs) of 
schizophrenia, bipolar disorder, and major depression were calculated in the adolescent 
sample using the log of the odds ratios from the latest Psychiatric Genomics Consortium 
GWAS of schizophrenia (PGC2) [Ripke et al., 2014], bipolar disorder [PGC Bipolar Disorder 
Working Group, 2011] and major depression [Ripke et al., 2013]. LD was controlled for 
using LD-based clumping with an r
2
-cutoff of 0.1 within a 250-kb window. For each 
individual, scores were generated using SNPs with the following p-value thresholds (pT): 
0.001, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, and 0.5. Linear regressions were performed in R and GEE 
was used to account for related individuals. Quantile plots were created to further examine 
the relationships. If there was evidence of a non-linear relationship from the quantile plots, 
the non-linear relationship was formalized by performing linear regression in a subset of 
individuals. 
To estimate the genetic covariance between psychotic-like experience domains and 
schizophrenia, bipolar disorder, and major depression, both LD-score regression and 
AVENGEME (Additive Variance Explained and Number of Genetic Effects Method of 
Estimation) were used [Bulik-Sullivan et al., 2015; Palla and Dudbridge, 2015]. 
AVENGEME uses the results of polygenic risk score analyses across multiple significance 
thresholds to estimate the model parameters including the genetic covariance. AVENGEME 
estimates 95% confidence intervals using profile likelihood method. There was no evidence 
of confounding or sample overlap in the mega-GWAS summary statistics, as such the 
heritability-intercept was constrained to 1 and the genetic covariance intercept was set to 0 in 
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LD-score regression. To improve the accuracy of the estimates of genetic covariance derived 
from the AVENGEME analysis, the SNP-heritability of liability for schizophrenia, bipolar 
disorder, and major depression were constrained to the LD-score regression estimates of 
SNP-heritability (see Supplementary Table 8).  
Oliver Pain et al. 13 
Results 
Table 1 shows the descriptive statistics of psychotic-like experience domains split by 
sample. The relationship between each psychotic-like experience domain with age and sex 
are available in Supplementary Tables 9 and 10. After phenotypic harmonization and quality 
control, the final sample sizes (including siblings) for all subsequent analyses were 8,665 for 
Paranoia and Hallucinations, 6,579 for Anhedonia, 6,297 for Cognitive Disorganization, and 
10,098 for Parent-rated Negative Symptoms. 
SNP-heritability estimates from meta-GREML and meta-LD-score regression were 
between 2.8-8.8% and 6.6-21.5% respectively (Table 2). Results from secondary analysis of 
SNP-heritability using the mega-analysis approach are given in Supplementary Table 11. 
The mega-GWAS identified no genome-wide significant variation for the Paranoia 
and Hallucinations, Cognitive Disorganization, or parent-rated Negative Symptoms domains. 
The mega-GWAS of Anhedonia identified one SNP (rs149957215) associated at genome-
wide significance (p = 3.76x10
-8
) within a gene called indoleamine 2,3-dioxygenase 2 (IDO2) 
(Supplementary Figure 1). This SNP was imputed in both samples included in the Anhedonia 
GWAS (TEDS and ALSPAC) with an average imputation quality (INFO) of 0.87 and minor 
allele frequency of 0.015. The minor allele frequency was similar in both TEDS (0.017) and 
ALSPAC (0.013). Due to limited LD with rs149957215, neighboring genetic variation 
showed no significant evidence of association. This association between rs149957215 and 
Anhedonia did not replicate in the independent TEDS replication sample, showing a non-
significant association (p=0.81) in the opposite direction. Several loci achieved suggestive 
significance (p<1x10
-5
) across the four psychotic-like experience domains (Supplementary 
Table 12, Supplementary Figures 2-5). There was no evidence of confounding with lambdas 
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of 0.99–1.01 and LD-score regression intercept of 1.00 in all analyses (Supplementary Figure 
6). 
Regional gene-based tests identified no gene that was significantly associated with 
any psychotic-like experience domain after Bonferroni correction for multiple testing. The 
top ten most associated genes for each psychotic-like experience domain are listed in 
Supplementary Table 13. 
Analysis of predicted frontal cortex gene expression associated with psychotic-like 
experience domains showed HACD2 as significantly differentially expressed for Cognitive 
Disorganization (Bonferroni corrected p = 6.83x10
-4
). The top ten genes showing differential 
expression for each psychotic-like experience domain are listed in Supplementary Table 14. 
The schizophrenia PRS significantly and positively predicted Anhedonia (p = 0.030
 
at 
pT = 0.10), Cognitive Disorganization (p = 0.035 at pT = 0.01) and Parent-rated Negative 
Symptoms (p = 5.41x10
-3 
at pT = 0.05) (Table 3; Figure 1). The bipolar disorder PRS 
significantly and negatively predicted Paranoia and Hallucinations only (p = 2.47x10
-3
 at pT 
= 0.010) (Table 3; Figure 1). The major depression PRS significantly and positively predicted 
Anhedonia (p = 0.010 at pT 0.5) and Parent-rated Negative Symptoms (p = 8.29x10
-3 
at pT = 
0.001) (Table 3; Figure 1). Supplementary Tables 15-17 and Supplementary Figures 7-9 
show the full results of these analyses. Logistic regression comparing PRSs in low and high 
psychotic-like experience domain groups (defined as bottom and top 25% of raw psychotic-
like experience sum scores) were congruent with linear analyses (Supplementary Table 18, 
Supplementary Figure 10).  
Quantile plots showing the mean PRS within subsets of the PE distributions 
highlighted one non-linear relationship between the schizophrenia PRS and Paranoia and 
Hallucinations, with the point of inflection at the median (Supplementary Figure 11). The 
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majority of individuals (81%) below the median had a raw score of zero. A single post-hoc 
analysis was performed to formalize the presence of this non-linear relationship. Post-hoc 
removal of individuals with a raw Paranoia and Hallucinations score of zero led to the 
schizophrenia PRS positively predicting Paranoia and Hallucinations (p = 7.90x10
-3
 at pT = 
0.001) (Table 3; Figure 1; Supplementary Table 15). Logistic regression comparing low and 
high groups of non-zero scoring individuals supported these findings (Supplementary Table 
18, Supplementary Figure 10). 
Table 4 presents the AVENGEME estimates of genetic covariance, which were 
highly congruent with the PRS analysis results. AVENGEME pools evidence across p-value 
thresholds tested from PRS analysis. As such, even when there is consistent but non-
significant evidence of association at individual p-value thresholds, AVENGEME genetic 
covariance estimates can be significant. Consequently, there were two significant results that 
were not shown by the PRS analyses; between the Anhedonia psychotic-like experience 
domain and bipolar disorder (genetic covariance = -0.022, 95%CI = -0.041 - -0.002), and the 
Cognitive Disorganization psychotic-like experience domain and major depression (genetic 
covariance = 0.033, 95%CI = 0.005 – 0.062). 
Table 4 presents estimates of genetic covariance from LD-score regression. LD-score 
regression mirrored over half of the significant associations shown between the equivalent 
polygenic risk scores and psychotic-like experience domains in Table 3. The genetic 
covariance between the schizophrenia PRS and non-zero scorers on Paranoia and 
Hallucinations could not be estimated because the genome-wide association analysis included 
zero scorers. Unlike for the equivalent results in Table 3, the genetic covariance between 
schizophrenia and anhedonia psychotic-like experience domain, and between major 
depression and parent-rated negative symptoms domain, were not significant.  
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Discussion 
A genetic relationship was identified between clinical schizophrenia and positive, 
cognitive, and negative psychotic-like experience trait domains in adolescence. A higher 
genetic risk for schizophrenia significantly predicted adolescents having more cognitive 
disorganization, anhedonia, and parent-rated negative symptoms, as well as more paranoia 
and hallucinations (this last finding was in the non-zero scorers). Thus our findings suggest 
that psychotic-like experience trait domains in adolescence comprise partly of the 
genetically-influenced phenotypic manifestation of schizophrenia. Furthermore, higher 
genetic risk for major depression significantly predicted having more self-rated anhedonia 
and parent-rated negative symptoms as a teenager. Our results discredit the hypothesis that 
psychotic-like experience trait domains in the general population are epiphenomena that do 
not share biological pathways with clinically-recognized psychiatric disorders. 
Genetic risk for schizophrenia and major depression in adulthood predicted 0.08–
0.09% variance in psychotic-like experience domains in adolescence. The effect sizes are 
likely downward biased because of the conservative approaches taken here to align different 
samples and to handle skewed variables. Nevertheless, comparable effect sizes have been 
reported in equivalent studies on other phenotypes, for example, linking social 
communication traits to genetic liability for autism [St Pourcain et al., 2017]. Large effect 
sizes were not expected. The upper limit of prediction is the degree to which polygenic risk 
scores for schizophrenia and major depression predict themselves (that is, their own 
phenotype) in an independent sample, which is ~18.4% for schizophrenia [Ripke et al., 2014] 
and ~0.6% for major depression [Ripke et al., 2013]. It is known from epidemiological 
studies that the magnitude of phenotypic association between psychotic-like experience 
domains and schizophrenia is modest [McGrath et al., 2016; Zammit et al., 2013] and far 
more people report psychotic-like experiences in adolescence than develop disorders such as 
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schizophrenia. Furthermore, there is considerable heterogeneity in schizophrenia and 
depression in terms of age of onset and symptom presentation. The associations were likely 
to be modest given their cross-phenotype and cross-age nature. The genetic association 
between psychiatric disorders and psychotic-like experience traits in the community may 
increase with age or with longitudinal assessments.  
A notable result was that paranoia and hallucinations during adolescence are 
associated with schizophrenia common genetic risk if individuals report at least some degree 
of paranoia or hallucinations, that is, the association was only present in the non-zero scorers. 
Individuals reporting no paranoia and hallucinations can exist anywhere on the schizophrenia 
genetic liability spectrum. Previous studies did not find a genetic association between 
schizophrenia and positive psychotic-like experiences [Jones et al., 2016; Zammit et al., 
2014; Sieradzka et al., 2014]. The use of quantitative traits and a large sample allowed the 
identification of this non-linear effect here. An explanation for the non-linear effect may lie 
in the variable age of onset of paranoia and hallucinations. Our study was focused on 
psychotic-like experiences in mid to late adolescence. It is predicted that stronger positive 
associations between genetic risk for schizophrenia and positive psychotic-like experiences 
will be found in samples assessed over a longer time frame, when anyone who is going to 
have paranoia and hallucinations has manifested them.  
The significant and positive genetic association between a self-rated anhedonia trait 
measure in adolescence and major depression in adulthood concurs with a previous report 
showing that subclinical depressive symptoms (including anhedonia) phenotypically predict 
major depressive episodes in adulthood [Pine et al., 1999]. Anhedonia is present as a 
symptom of both schizophrenia and depression in psychiatric diagnoses, and our research 
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shows that as a trait dimension in adolescence it shares common genetic underpinnings with 
both schizophrenia and depression.  
The significant negative association between paranoia and hallucinations and bipolar 
disorder genetic risk also deserves discussion. Previous research reported the presence of 
paranoia, hallucinations, and delusions prior to the onset of bipolar disorder [McGrath et al., 
2016]. However, our results suggest that genetic influences on paranoia and hallucinations as 
traits during mid-adolescence are negatively associated with known common genetic risk 
associated with diagnosed bipolar disorder. The common genetic relationship between 
adolescent paranoia and hallucinations and bipolar disorder requires replication in an 
independent sample. Further insight into this relationship will also be gained as more 
powerful polygenic predictors for bipolar disorder become available. 
Although in many cases the SNP-heritability estimates were not significantly non-
zero, the point estimates of SNP-heritability indicate that common genetic variation 
influences psychotic-like experience domains during adolescence. This concurs with results 
from twin studies reporting significant twin heritability estimates [Zavos et al., 2014]. 
The SNP that achieved genome-wide significance in the mega-GWAS for anhedonia 
lies within the protein-coding gene IDO2. IDO2 is a key enzyme in the regulation of the 
kynurenine pathway, which upon stimulation by proinflammatory cytokines, converts 
tryptophan into kynurenine. It has been reported that increased metabolism of tryptophan to 
kynurenine is associated with increased depressive symptoms via the increased production of 
cytotoxic kynurenine metabolites [Wichers et al., 2005; Dantzer et al., 2011; Myint et al., 
2007]. In fact, a previous study has reported a significant correlation between kynurenine 
production and anhedonia in an adolescent sample [Gabbay et al., 2012]. These previous 
studies suggest the association between IDO2 and anhedonia is plausible. However, this 
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association should be interpreted with caution as rs149957215 was imputed in all three 
samples, has a low minor allele frequency of 0.013, and appears to be uncorrelated with 
surrounding common genetic variation. Furthermore, this association failed to replicate in a 
sufficiently powered independent sample. 
Some methodological details deserve consideration. A key strength of the study is the 
derivation of psychometrically-sound quantitative individual psychotic-like experience 
domains: these were derived using principal component analysis and have content validity. It 
is noted that our terminology of psychotic-like experiences, like others [Stefanis et al., 2002; 
Wigman et al., 2011; Alemany et al., 2013], includes positive, cognitive and negative 
psychotic-like experiences, for the reason that at the extreme these experiences are 
characteristic of clinical psychotic disorders. Greater power was achieved compared to past 
research through combining independent samples. At the same time, slight variations in 
measure items across samples impacts the amount of phenotypic variance that can be 
explained by common genetic variation. The correlation between specific psychotic-like 
experiences were typically consistent within each sample, however the relationship between 
Paranoia and Hallucinations and other psychotic-like experiences did vary to some degree 
(Supplemental Table 6). For the more skewed psychotic-like experience domains with larger 
numbers of tied individuals, the process of randomly ranking tied individuals during 
normalization was essential but will have introduced noise and thus downward biased SNP-
heritability estimates. This study used multiple PRS selection thresholds (referred to as pTs), 
however the p-values for each selection threshold result have not been corrected for multiple 
testing. Due to the high correlation between PRS selection thresholds, even when considering 
all possible selection thresholds, it has been estimated that a significance threshold of p = 
0.001 is appropriate [Euesden et al., 2015]. This threshold would be overly conservative in 
our study as we only tested a limited number of thresholds. Genetic covariance estimates 
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obtained by AVENGEME (Table 3) take all selection thresholds into account simultaneously, 
and therefore need no adjustment for multiple testing. We note that the significance of the 
PRS associations are supported by the confidence intervals of the AVENEMGE genetic 
covariance estimates. This study has identified significant common genetic covariance 
between several psychotic-like experiences and psychiatric disorders. It remains possible that 
the genetic covariance estimates could be partly explained by the presence of adolescents 
with diagnosed relatives. If an adolescent has a relative with schizophrenia for example, the 
adolescent may have increased psychotic-like experiences due to their shared environment 
with the relative.  However, twin and adoption studies of schizophrenia and psychotic-like 
experiences do not support this mode of transmission.  Finally, each psychotic-like 
experience domain was viewed as a single phenotype of interest in its own right. As such, 
this study was treated as a series of self-contained individual trait studies, rather than as a 
single exploratory study across traits. Therefore we did not formally correct for multiple 
testing of traits, similar to other studies of this nature [Consortium, 2007; Cross-Disorder 
Group of the Psychiatric Genomics Consortium, 2013].  Note however that nearly all of our 
associations would remain significant after correction for testing four PE domains, while the 
association of rs149957215 with Anhedonia (p=3.76e-8) did not replicate. 
Collectively, these findings reveal novel evidence for some shared common genetic 
etiology between psychotic-like experience domains in mid to late adolescence and 
clinically-recognized psychiatric disorders in adulthood. Evidence is accruing that psychotic-
like experiences manifested prior to adulthood form part of a wider phenotype or prodrome 
related to psychiatric disorders such as schizophrenia and depression. This study joins the 
existing evidence that individuals with a family history of schizophrenia score higher on 
psychotic-like experience scales [Zavos et al., 2014; Jeppesen et al., 2014], psychotic-like 
experiences are associated with the same environmental risk factors as schizophrenia 
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[Linscott and Van Os, 2013], psychotic-like experiences are on a phenotypic and etiological 
continuum across the severity continuum [Zavos et al., 2014; Taylor et al., 2016], and 
psychotic-like experiences predict later psychiatric disorders [McGrath et al., 2016; Fisher et 
al., 2013; Zammit et al., 2013; Cederlöf et al., 2016; Kelleher et al., 2014; Werbeloff et al., 
2012; Kelleher et al., 2012]. The next step is to consider how psychotic-like experiences can 
be harnessed in a practical sense as a (small effect size) red flag for risk in early intervention 
and prevention strategies. Similar to family history, psychotic-like experiences might be a 
useful heuristic even if the majority of individuals with psychotic-like experiences will 
remain unaffected by psychiatric disorders. 
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Footnotes 
None. 
Table/Figure Legends 
Table I. Descriptive statistics for psychotic-like experience domains in each sample. These 
figures are based on the individuals remaining after quality control and were used in all 
subsequent genetic analyses. 
Table II. SNP-heritability estimates for psychotic-like experience domains. 
Table III. Schizophrenia, bipolar disorder, and major depression polygenic risk scores 
predicting psychotic-like experience domains in adolescents. This table shows results for 
polygenic risk scores at the most predictive p-value threshold for each trait. 
Table IV. Genetic covariance between each psychotic-like experience domain and 
schizophrenia, bipolar disorder, and major depression. 
Figure Titles 
Figure 1. Polygenic risk scores for schizophrenia, bipolar disorder, and major depression 
predict adolescent psychotic-like experience domains. This figure shows results for polygenic 
risk scores at the most predictive p-value threshold for each trait. Error bars are 95% 
confidence intervals (95% CI). 
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Tables 
Table I 
TEDS
f
 
       
Specific PE μ
a
 σ
b
 Range Skew α
c
 N
d
 N sibs
e
 
Paranoia and 
Hallucinations 
0.43 0.51 0 - 3.90 2.03 0.73 2994 827 
Anhedonia 3.19 1.54 0 - 9.80 0.53 0.79 2988 821 
Cognitive 
Disorganization 
3.83 2.82 0 - 11.00 0.51 0.77 2987 823 
Parent-rated 
Negative 
Symptoms 
0.88 1.19 0 - 9.33 2.35 0.84 2995 833 
        
ALSPAC
g
 
       
Specific PE μ
a
 σ
b
 Range Skew α
c
 N
d
 N sibs
e
 
Paranoia and 
Hallucinations 
0.27 0.51 0 - 4.17 2.78 0.67 3591 0 
Anhedonia 1.42 1.19 0 - 7.00 1.09 0.73 3591 0 
Parent-rated 
Negative 
Symptoms 
1.57 1.11 0 - 7.00 0.61 0.61 4019 0 
        
CATSS
h
 
       
Specific PE μ
a
 σ
b
 Range Skew α
c
 N
d
 N sibs
e
 
Paranoia and 
Hallucinations 
0.20 0.43 0 - 5.00 3.92 0.73 2080 849 
Cognitive 
Disorganization 
1.95 0.98 0 - 5.00 0.35 0.79 3310 1335 
Parent-rated 
Negative 
Symptoms 
0.57 0.95 0 - 8.50 2.64 0.75 3084 1395 
a
 Mean,  
b
 Standard deviation 
c
 Standardized Cronbach's alpha 
d
 Number of genotyped individuals after exclusions 
e
 Number of siblings pairs within N 
f
 Twins Early Development Study 
g
 Avon Longitudinal Study of Parents and Children 
h
 Child and Adolescent Twin Study in Sweden 
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Table II 
Specific PE 
meta-GREML meta-LDSC 
SNP-h2 a SE p SNP-h2 a SE p 
Paranoia and 
Hallucinations 
0.028 0.050 0.293 0.066 0.068 0.168 
Anhedonia 0.088 0.055 0.057 0.204 0.078 4.51x10-3 
Cognitive 
Disorganization 
0.059 0.063 0.176 0.215 0.085 5.79x10-3 
Parent-rated 
Negative Symptoms 
0.059 0.045 0.096 0.119 0.061 0.026 
 
a
 Phenotypic variance explained by tagged common genetic variation.   
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Table III 
Schizophrenia 
     
Specific PE β SE p r
2 pT
a
 
Paranoia and Hallucinations -0.005 0.011 0.664 0.002% 0.200 
Paranoia and Hallucinations 
excl. zero-scorers 
0.031 0.012 7.90E-03 0.094% 0.001 
Anhedonia 0.028 0.013 0.030 0.079% 0.100 
Cognitive Disorganisation 0.029 0.014 0.035 0.083% 0.010 
Parent-rated Negative 
Symptoms 
0.030 0.011 5.41E-03 0.088% 0.050 
 
 
  
 
 Bipolar Disorder 
 
  
 
 
Specific PE β SE p r
2 pT
a
 
Paranoia and Hallucinations -0.034 0.011 2.47E-03 0.115% 0.010 
Anhedonia -0.017 0.013 0.178 0.030% 0.100 
Cognitive Disorganisation -0.013 0.014 0.333 0.017% 0.001 
Parent-rated Negative 
Symptoms 
-0.009 0.011 0.388 0.008% 0.500 
 
 
  
 
 Major Depression 
 
  
 
 
Specific PE β SE p r
2 pT
a
 
Paranoia and Hallucinations 0.006 0.011 0.589 0.004% 0.100 
Anhedonia 0.033 0.013 0.010 0.109% 0.500 
Cognitive Disorganisation 0.018 0.014 0.189 0.033% 0.050 
Parent-rated Negative 
Symptoms 
0.028 0.011 8.29E-03 0.078% 0.001 
 
   a p-value threshold used to select when calculating polygenic risk scores 
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Table IV 
Schizophrenia 
      
Specific PE 
AVENGEME LDSC 
cov(G)
a
 
Low 
95% CI 
High 
95% CI cov(G)
a
 SE p 
Paranoia and Hallucinations -0.002 -0.013 0.008 -0.003 0.014 0.844 
Paranoia and Hallucinations 
excl. zero-scorers 
0.019 0.011 0.029 NA NA NA 
Anhedonia 0.024 0.013 0.038 0.021 0.016 0.184 
Cognitive Disorganisation 0.025 0.013 0.040 0.054 0.018 3.52x-03 
Parent-rated Negative 
Symptoms 
0.025 0.015 0.036 0.047 0.014 5.57E-04 
       Bipolar Disorder 
      
Specific PE 
AVENGEME LDSC 
cov(G)
a
 
Low 
95% CI 
High 
95% CI cov(G)
a
 SE p 
Paranoia and Hallucinations -0.032 -0.048 -0.018 -0.045 0.022 0.039 
Anhedonia -0.022 -0.041 -0.002 0.008 0.028 0.767 
Cognitive Disorganisation 0.008 -0.013 0.029 0.021 0.028 0.451 
Parent-rated Negative 
Symptoms 
-0.010 -0.026 0.006 0.009 0.021 0.669 
       Major Depressive Disorder 
      
Specific PE 
AVENGEME LDSC 
cov(G)
a
 
Low 
95% CI 
High 
95% CI cov(G)
a
 SE p 
Paranoia and Hallucinations 0.004 -0.018 0.026 0.013 0.020 0.523 
Anhedonia 0.065 0.037 0.094 0.061 0.023 7.50E-03 
Cognitive Disorganisation 0.033 0.005 0.062 0.015 0.028 0.594 
Parent-rated Negative 
Symptoms 
0.023 0.010 0.042 0.031 0.020 0.119 
       a Genetic covariance 
 
 
 
 
 
